Fluidotherapy in Patients With Distal Radius Fractures

April 9, 2025 updated by: Levent Horoz, Ahi Evran University Education and Research Hospital

Effectiveness of Fluidotherapy in Patients With Conservatively Treated Distal Radius Fractures

Distal radius fractures are the most common fractures when looking at upper extremity fractures. The incidence of distal radius fractures is increasing day by day, and when looking at the databases of various countries, its annual prevalence reaches 70,000 in the UK and 640,000 in the USA. Most of these fractures are related to osteoporosis and require appropriate treatment. If not, it causes loss of work force, permanent disability, and limitation in daily activities.

Fluidotherapy has also proven to be effective in reducing hand edema in patients with carpal tunnel syndrome and stroke, examining its effect on nerve conduction velocities, and warming hypothermic patients. Compared to these treatment methods, fluid therapy reduces both joint capsule and muscle temperature by 9°C and 5.7°C, respectively. has been reported to increase.

Study Overview

Detailed Description

Reducing pain and edema after Distal Radius fracture is an important part of postoperative rehabilitation. Various massage and mobilization methods were applied to this patient population in the postoperative period. In a recent study evaluating the effectiveness of Whirlpool treatment, it was reported that studies on the effectiveness of fluidotherapy are also needed. There is no study in the literature evaluating the effectiveness of fluidotherapy in the postoperative rehabilitation program in patients who underwent surgery for distal radius fractures.

This study aimed to evaluate the effect of adding fluidotherapy to the early rehabilitation program on pain, edema, joint range of motion and functionality after the cast is removed in patients who received conservative cast treatment due to distal radius fracture.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kişrsehşr
      • Kirsehir, Kişrsehşr, Turkey, 40100
        • Kirsehir Research and Training Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

-Treating with a cast due to distal radius fracture being over 18 years old

Exclusion Criteria:

  • Presence of polytrauma
  • History of previous limb-related surgery
  • Hemiplegia in the involved limb
  • Contracture in the involved limb
  • Arterial and venous occlusions
  • Lymphatic system disorders
  • Heart and circulatory system disorders
  • Hepatitis, Measles, Sepsis infectious diseases or fever
  • Open wound on the applied hand.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Only the conventional rehabilitation program will be applied by a physiotherapist for 6 weeks.
The conventional rehabilitation program determined before the study will be implemented by a physiotherapist in the hospital for 6 weeks.
Experimental: Fluidotherapy Group
Fluidotherapy will be applied to the group in addition to the conservative rehabilitation program received by the control group. Fluidotherapy will be applied 20 minutes a day, 5 days a week for 4 weeks.
Fluidotherapy is a dry environment created by mobilizing solid particles using heated air flow. Fluidotherapy will be applied 20 minutes a day, 5 days a week for 4 weeks.
The conventional rehabilitation program determined before the study will be implemented by a physiotherapist in the hospital for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wrist joint range of motion
Time Frame: 6th week
Wrist joint range of motion: Measurement of wrist joint range of motion (ROM) with a goniometer is the most frequently used method in clinical practice that provides objective evaluation and error-free measurement. In our study, wrist ROM measurements will be made with a goniometer using the neutral zero method. This method is a painless and non-invasive measurement method.
6th week
Wrist joint range of motion
Time Frame: Baseline
Wrist joint range of motion: Measurement of wrist joint range of motion (ROM) with a goniometer is the most frequently used method in clinical practice that provides objective evaluation and error-free measurement. In our study, wrist ROM measurements will be made with a goniometer using the neutral zero method. This method is a painless and non-invasive measurement method.
Baseline
Wrist joint range of motion
Time Frame: 2th week
Wrist joint range of motion: Measurement of wrist joint range of motion (ROM) with a goniometer is the most frequently used method in clinical practice that provides objective evaluation and error-free measurement. In our study, wrist ROM measurements will be made with a goniometer using the neutral zero method. This method is a painless and non-invasive measurement method.
2th week
Visual analog scale
Time Frame: Baseline
Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale.A score of 0 indicates the best result, a score of 10 indicates the worst result. Higher scores indicate higher pain.
Baseline
Visual analog scale
Time Frame: 2th week
Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale.A score of 0 indicates the best result, a score of 10 indicates the worst result. Higher scores indicate higher pain.
2th week
Visual analog scale
Time Frame: 6th week
Visual analog scale (VAS) was used for pain assessment. VAS is a 10-point Likert scale.A score of 0 indicates the best result, a score of 10 indicates the worst result. Higher scores indicate higher pain.
6th week
Circumference (mm)
Time Frame: Baseline
Environmental Measurement; the both hands and wrists of the patient will be measured with the help of a tape measure using the figure of eight method. The cm difference between both upper extremities will be recorded.
Baseline
Circumference (mm)
Time Frame: 2th week
Environmental Measurement; the both hands and wrists of the patient will be measured with the help of a tape measure using the figure of eight method. The cm difference between both upper extremities will be recorded.
2th week
Circumference (mm)
Time Frame: 6th week
Environmental Measurement; the both hands and wrists of the patient will be measured with the help of a tape measure using the figure of eight method. The cm difference between both upper extremities will be recorded.
6th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gross Grip Strength:
Time Frame: Baseline
Jamar dynamometer wii use to evaluate gross grip strength.Higher values indicate increased grip strength
Baseline
Gross Grip Strength:
Time Frame: 2th week
Jamar dynamometer wii use to evaluate gross grip strength.Higher values indicate increased grip strength
2th week
Gross Grip Strength:
Time Frame: 6th week
Jamar dynamometer wii use to evaluate gross grip strength.Higher values indicate increased grip strength
6th week
Patient-Rated Wrist Evaluation (PRWE) questionnaire
Time Frame: Baseline

Patient-Rated Wrist Evaluation (PRWE) questionnaire: PRWE is a 15-item questionnaire.High scores indicate functional impairment designed to measure wrist pain and disability in activities of daily living.The maximum score that can be obtained from the pain subscale is 50 and the minimum is 0.

The maximum score that can be obtained from the function subscale is 50 and the minimum is 0.

Baseline
Patient-Rated Wrist Evaluation (PRWE) questionnaire
Time Frame: 2th week

Patient-Rated Wrist Evaluation (PRWE) questionnaire: PRWE is a 15-item questionnaire.High scores indicate functional impairment designed to measure wrist pain and disability in activities of daily living.The maximum score that can be obtained from the pain subscale is 50 and the minimum is 0.

The maximum score that can be obtained from the function subscale is 50 and the minimum is 0.

2th week
Patient-Rated Wrist Evaluation (PRWE) questionnaire
Time Frame: 6th week

Patient-Rated Wrist Evaluation (PRWE) questionnaire: PRWE is a 15-item questionnaire.High scores indicate functional impairment designed to measure wrist pain and disability in activities of daily living.The maximum score that can be obtained from the pain subscale is 50 and the minimum is 0.

The maximum score that can be obtained from the function subscale is 50 and the minimum is 0.

6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Levent Horoz, Asst Prof, Kirsehir Research and Training Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2024

Primary Completion (Actual)

January 24, 2025

Study Completion (Actual)

February 24, 2025

Study Registration Dates

First Submitted

February 16, 2024

First Submitted That Met QC Criteria

February 16, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 9, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Fluidotherapy

Subscribe